Cardiovascular Disease Risk 3
Ginagamit ito bilang biologically active na pampadagdag sa pagkain — dagdag na pinagmumulan ng mga bitamina — B2, B6, C, mga organikong asido — mansanas, succinic, glutamine. Mga sangkap: malic acid, succinic acid, glutamic acid, badan extract, ascorbic acid, bitamina B2, B6.
>>> ПЕРЕЙТИ НА ОФИЦИАЛЬНЫЙ САЙТ <<<
I am happy to offer you a scientific Text on the topic of cardiovascular disease: risk level 3 in English: Cardiovascular disorders: characteristics and Management in high-risk stage 3 Introduction Cardiovascular disease (CVD) is the leading cause of death. The classification into different risk levels allows for a differentiated prevention and therapy. Risk level 3, also known as high risk, which includes people with pre-existing cardiovascular disease or significant risk factors, a significantly increased cardiovascular event risk in the course of 10 years. Definition and criteria for risk level 3 To belong to a risk level of 3 patients who meet at least one of the following criteria: known clinically manifest cardiovascular disease (e.g., coronary heart disease, cerebrovascular disease, peripheral arterial disease); diabetes mellitus with organ involvement (micro‑ or macro-angiopathy) or additional risk factors; severe chronic renal failure (GFR < 30\ \text{ml/min/1{,}73\ m^2}); very elevated levels of individual risk factors (e.g., LDL‑cholesterol ≥5 mmol/l, blood pressure ≥180/110 mmHg); the combined presence of several moderate risk factors, which together result in a high total risk (according to the SCORE risk scale: the overall risk of ≥10% for a fatal cardiovascular event in 10 years). Main Risk Factors The most important modifiable risk factors in high-risk stage 3 are: arterial hypertension; Dyslipidemia (elevated LDL cholesterol, low HDL‑cholesterol); Diabetes mellitus; Smoking; Overweight and obesity; lack of physical activity; unhealthy diet; chronic Stress. Non-modifiable factors include age (men ≥40 years, women ≥50 years of age or postmenopausal), family history of early cardiovascular events, as well as genetic predispositions. Diagnostics A comprehensive diagnosis in patients of the risk level 3 includes: History and physical examination (measurement of blood pressure, BMI calculation, clarification of symptoms). Laboratory tests: lipid spectrum of blood glucose, HbA1c, renal parameters (creatinine, eGFR), urinary analysis. Instrumental: 12‑channel ECG, echocardiography, and possibly Stress ECG or stress echocardiography. In the case of specific suspicion: coronary angiography, CT‑angiography, ultrasound of the Carotids. Therapeutic Strategies The Management of patients in high-risk stage 3 requires a multi-modal treatment: Drug Therapy: Antihypertensives (e.g., ACE inhibitors, AT1 antagonists, beta-blockers, diuretics); Lipid-lowering drugs (statins as a treatment cob, if necessary, ezetimibe, PCSK9 inhibitors); Antidiabetic drugs with cardiovascular Benefits (e.g., SGLT2 inhibitors, GLP‑1 receptor agonists); Platelet aggregation inhibitors (e.g., acetylsalicylic acid) in the case of indication; if necessary, additional drugs for symptom control (nitrates, antiarrhythmics). Lifestyle changes: Smoking cessation; healthy diet (DASH diet, Mediterranean diet); regular physical activity (at least 150 minutes of moderate load per week); Weight reduction in obesity (goal: BMI <25 kg/m 2 ); Stress management and adequate sleep. Regular Follow-Up: Blood pressure control; Monitoring of blood fats and blood sugar levels; Adjustment of the medication after the course and side effects; Training and Motivation of the patient (cardiac rehabilitation programs). Conclusion Patients with cardiovascular risk level 3 require an intensive, individualized and multidisciplinary care. Through the combined application of evidence-based medications and sustainable lifestyle changes in the risk for cardiovascular events is significantly lower, and the quality of life and life expectancy improve. Early identification and targeted Intervention for those in this high-risk group constitutes a key to the reduction of cardiovascular morbidity and mortality. If you wish, I can make certain sections in more detail, or other aspects add!
People have long used Hawthorne berries for treating high bp, heart issues, and cholesterol levels. A number of Clinical research conclude that it improves cardiovascular function, shortness of breath, and fatigue. In another study, 1200 mg hawthorn extract or placebo was taken by hypertension patients for 16 weeks. Those who were taking hawthorn extract had a significant decrease in blood pressure than the other group taking a placebo. Cardiovascular Disease Risk 3. Constant high levels of stress can disturb the blood flow and blood pressure and can damage vessels, and you may experience dizziness, extreme fatigue, or body aches with no wish to get out of bed. This stress-induced fatigue can make your blood pressure high and needs to be monitored.
Cardiovascular Diseases Of The Army
Of what is high blood pressure that arises in simple words
NSAIDs in cardiovascular diseases
How to determine cardiovascular diseases
http://types.poligonmz.ru/articles/47670-what-pills-high-blood-pressure-cause-cough.html
https://mytube.by/articles/2833-cardiovascular-disease-germanyer-area.html
Una sa lahat, ang mga Beta-blocker ay karaniwang ibinibigay sa mga pasyente na may heart failure, aortic aneurysm, pagkatapos ng myocardial infarction, at sa mga kababaihan na nasa edad ng pagbubuntis, lalo na sa mga kababaihang nagpaplano ng pagbubuntis. Madalas matanggap ng katawan ang Beta-blocker, pero maaari rin itong magdulot ng pantal sa balat at bradycardia – sobrang bagal ng tibok ng puso. Constant high levels of stress can disturb the blood flow and blood pressure and can damage vessels, and you may experience dizziness, extreme fatigue, or body aches with no wish to get out of bed. This stress-induced fatigue can make your blood pressure high and needs to be monitored.